
1. biochemistry. 2020 mar 3;59(8):911-920. doi: 10.1021/acs.biochem.9b01105. epub
2020 feb 24.

tafenoquine: step toward malaria elimination.

lu ky(1), derbyshire er(1)(2).

author information: 
(1)department molecular genetics microbiology, school medicine, duke
university, durham, north carolina 27708, united states.
(2)department chemistry, duke university, durham, north carolina 27708, united
states.

there pressing need compounds broad-spectrum activity against
malaria parasites various life cycle stages achieve malaria elimination.
however, goal cannot accomplished without targeting tenacious dormant
liver-stage hypnozoite causes multiple relapses first episode of
illness. search magic bullet radically cure plasmodium vivax
malaria, tafenoquine outperformed candidate drugs approved the
u.s. food drug administration 2018. tafenoquine 8-aminoquinoline
that inhibits multiple life stages various plasmodium species. additionally,
its much longer half-life allows single-dose treatment, improve
the compliance rate. despite approval long-time use other
8-aminoquinolines, mechanisms behind tafenoquine's activity adverse
effects still largely unknown. perspective, discuss plausible 
underlying mechanisms tafenoquine's antiparasitic activity highlight its
role cellular stressor. also discuss potential drug combinations 
development next-generation 8-aminoquinolines improve the
therapeutic index tafenoquine malaria treatment prevention.

doi: 10.1021/acs.biochem.9b01105 
pmid: 32073254  [indexed medline]

